NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health announced a quarterly dividend on Wednesday, May 9th. Shareholders of record on Monday, July 2nd will be given a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 annualized dividend and a dividend yield of 3.51%. The ex-dividend date is Friday, June 29th. This is a positive change from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health declared that its board has authorized a share buyback plan on Thursday, February 8th 2018, which permits the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company's management believes its stock is undervalued.

Cardinal Health Inc (NYSE:CAH) released its earnings results on Thursday, May, 3rd. The company reported $1.39 EPS for the quarter, missing the Zacks' consensus estimate of $1.51 by $0.12. The business earned $33.63 billion during the quarter, compared to the consensus estimate of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.42.

15 brokerages have issued 12 month price targets for Cardinal Health's shares. Their predictions range from $55.00 to $85.00. On average, they expect Cardinal Health's share price to reach $69.7692 in the next year. View Analyst Ratings for Cardinal Health.

Cardinal Health saw a decline in short interest in May. As of May 15th, there was short interest totalling 9,109,975 shares, a decline of 33.6% from the April 30th total of 13,723,348 shares. Based on an average daily trading volume, of 5,195,453 shares, the short-interest ratio is presently 1.8 days. Approximately 2.9% of the shares of the company are sold short. View Cardinal Health's Current Options Chain.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

Media stories about CAH stock have trended somewhat positive on Wednesday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardinal Health earned a daily sentiment score of 0.19 on Accern's scale. They also assigned media coverage about the company an impact score of 46.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Cardinal Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.73%), Barrow Hanley Mewhinney & Strauss LLC (5.98%), American International Group Inc. (2.51%), Boston Partners (1.94%), Franklin Resources Inc. (1.81%) and Northern Trust Corp (1.37%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Element Capital Management LLC, Franklin Resources Inc., JPMorgan Chase & Co., American Century Companies Inc., BlackRock Inc., Thompson Siegel & Walmsley LLC, LSV Asset Management and DekaBank Deutsche Girozentrale. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Boston Partners, Pzena Investment Management LLC, Point72 Asset Management L.P., Schwab Charles Investment Management Inc., Barrow Hanley Mewhinney & Strauss LLC, Russell Investments Group Ltd., Wedge Capital Management L L P NC and Roystone Capital Management LP. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $54.25.

Cardinal Health has a market capitalization of $16.47 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]